🔎 Trials Near Me

Utama › Serangan Jantung › California

Kajian klinikal Serangan Jantung di California

5 kajian untuk Serangan Jantung sedang mencari peserta di lokasi di California.

Bandar di California

Teks kajian rasmi (Bahasa Inggeris)

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • National Institute of Clinical Research, Bakersfield
  • California Institute of Renal Research, Chula Vista
  • The Medical Research Group, Inc., Fresno
  • dan 27 lagi
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05485961

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

  • Cardiovascular Res Found, Beverly Hills
  • National Heart Institute, Beverly Hills
  • Diabetes Lipid Management Center, Huntington Beach
  • dan 7 lagi
Mengambil pesertaFasa 3
Umur 18 hingga 100 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07517263

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  • National Heart Institute, Beverly Hills
  • 310 Clinical Research, Inglewood
  • University of California San Diego, La Jolla
  • dan 11 lagi
Mengambil pesertaFasa 3
Umur 50 hingga 105 · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT07136012

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

  • Orange County Heart Institute, Orange
  • Peerbridge Health, Pasadena
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Jun 2026 · NCT06699056

Focused Orticumab Research for Treating Inflammation in Coronary Arteries

  • Abcentra Investigational Site, Los Angeles
  • Abcentra Investigational Site, Torrance
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Jan 2026 · NCT06927739

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.